Product
Veru-111
1 clinical trial
2 indications
Indication
Respiratory Distress SyndromeIndication
AdultClinical trial
Randomized, Placebo-Controlled, Phase 2 Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)Status: Completed, Estimated PCD: 2020-12-18